Erenumab Tied to Rapid Conversion From Chronic to Acute Migraine Erenumab Tied to Rapid Conversion From Chronic to Acute Migraine

The anti-calcitonin gene-related peptide (CGRP) monoclonal antibody erenumab is associated with rapid and sustained conversion from chronic to episodic migraine, new research suggests.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news